{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:14:59Z","timestamp":1722417299257},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.2169\/internalmedicine.7873-21","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T22:09:39Z","timestamp":1639174179000},"page":"1995-1998","source":"Crossref","is-referenced-by-count":2,"title":["Chylous Ascites Due to Hyperthyroidism and Heart Failure"],"prefix":"10.2169","volume":"61","author":[{"given":"Masaki","family":"Uchihara","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"},{"name":"Department of Professional Development, Tokyo Medical and Dental University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ehara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"},{"name":"Department of Pulmonary Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Iwanami","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"},{"name":"Department of Rheumatology, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Endocrinology and Diabetes, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Endocrinology and Diabetes, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ishizuka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"},{"name":"Department of Family Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Hiraoka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Press OW, Press NO, Kaufman SD. Evaluation and management of chylous ascites. Ann Intern Med 96: 358-364, 1982.","DOI":"10.7326\/0003-4819-96-3-358"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous ascites: a review of pathogenesis, diagnosis and treatment. J Clin Transl Hepatol 6: 1-9, 2018.","DOI":"10.14218\/JCTH.2017.00035"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lizaola B, Bonder A, Trivedi HD, Tapper EB, Cardenas A. Review article: the diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther 46: 816-824, 2017.","DOI":"10.1111\/apt.14284"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Al-Busafi SA, Ghali P, Desch\u00eanes M, Wong P. Chylous ascites: evaluation and management. ISRN Hepatol 2014: 1-10, 2014.","DOI":"10.1155\/2014\/240473"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hsieh M-H, Chen C-C, Wang T-Y, Chang C-T. Chylous ascites as a manifestation of thyrotoxic cardiomyopathy in a patient with untreated Graves' disease. Thyroid 20: 653-655, 2010.","DOI":"10.1089\/thy.2010.0020"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Hiroi N, Sakamoto Y, Urita Y, Higa M, Kuboki K, Yoshino G. Graves' disease with intractable diarrhea, chylous ascites, and chylothorax: a case report. Thyroid 17: 1299-1303, 2007.","DOI":"10.1089\/thy.2007.0006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ridruejo E, Mand\u00f3 OG. Chylous ascites as the main manifestation of left ventricular dysfunction: a case report. BMC Gastroenterol 5: 1-4, 2005.","DOI":"10.1186\/1471-230X-5-25"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Villena V, De Pablo A, Martin-Escribano P. Chylothorax and chylous ascites due to heart failure. Eur Respir J 8: 1235-1236, 1995.","DOI":"10.1183\/09031936.95.08071235"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cakmak HA, Yenid\u00fcnya G, Karada\u011f B, Ongen Z. Development of chylothorax and chylous ascites in a patient with congestive heart failure. Turk Kardiyol Dern Ars 39: 495-498, 2011.","DOI":"10.5543\/tkda.2011.01447"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tr\u00eapa M, Baggen Santos R, Fontes Oliveira M, Silveira I, Pires J, Torres S. Val30Met familial amyloid polyneuropathy, heart failure, and chylous ascites: an unexpected combination. Rev Esp Cardiol 72: 431-433, 2019.","DOI":"10.1016\/j.rec.2018.04.019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 22: 263-277, 1993.","DOI":"10.1016\/S0889-8529(18)30165-8"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Akamizu T, Satoh T, Isozaki O, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid 22: 661-679, 2012.","DOI":"10.1089\/thy.2011.0334"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ogasawara M, Harada K, Tamura M, Ito T, Kishkurno S, Takada G. Chylous ascites associated with atrioventricular valve regurgitation after Blalock-Taussig shunt. J Pediatr Gastroenterol Nutr 23: 501-503, 1996.","DOI":"10.1097\/00005176-199611000-00028"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Starling E. The influence of mechanical factors on lymph production. J Physiol 16: 224-267, 1894.","DOI":"10.1113\/jphysiol.1894.sp000500"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 49: 2087-2107, 2009.","DOI":"10.1002\/hep.22853"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Farias AQ, Silvestre OM, Garcia-Tsao G, et al. Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study. Hepatology 59: 1043-1051, 2014.","DOI":"10.1002\/hep.26643"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/13\/61_7873-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:15:12Z","timestamp":1715231712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/13\/61_7873-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":16,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7873-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"article-number":"7873-21"}}